8: ASCO 2025 Debrief: Key Updates in Genitourinary Cancer Management

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/ef/2b/a5/ef2ba566-14c5-0829-65e4-66b8116de434/mza_10513040257090650742.png/600x600bb.jpg

Oncology Decoded

17 episodes

2 weeks ago

Experts highlight anticipated sessions at the 2025 ESMO Congress, including those on the PSMAddition and EV-303 trials.

All content for Oncology Decoded is the property of Oncology Decoded and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Experts highlight anticipated sessions at the 2025 ESMO Congress, including those on the PSMAddition and EV-303 trials.

Science

8: ASCO 2025 Debrief: Key Updates in Genitourinary Cancer Management

Oncology Decoded

50 minutes

4 months ago

8: ASCO 2025 Debrief: Key Updates in Genitourinary Cancer Management

Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss abstracts from the 2025 ASCO Annual Meeting that may impact genitourinary cancer care.